Institutional members access full text with Ovid®

Breast cancer screening in women aged 5074 years: isthereroom for improvement?

Morère, Jean-Françoisa,b; Pivot, Xavierc,d; Viguier, Jérômee; Blay, Jean-Yvesf,g; Calazel-Benque, Anneh; Coscas, Yvani; Roussel, Clairej; Eisinger, Françoisk,l

European Journal of Cancer Prevention: January 2011 - Volume 20 - Issue - p S8–S12
doi: 10.1097/01.cej.0000391562.18512.4a
Supplement Articles

Regular mammography screening has been available in France, free of charge, for all women aged 50–74 years since 2005. Two nationwide surveys [EDIFICE 1 (507 women interviewed; age 50–74 years) and EDIFICE 2(488women)] recently collected data on individuals' access to cancer screening procedures. Two further surveys interviewed 600 general practitioners (GPs) each to determine their attitudes towards screening in general andscreening for breast cancer in particular. The method of quotas ensured the populations surveyed were representative. In 2005, 93%, and in 2008, 94% of women reported having undergone a screening mammography. Anage-related effect was apparent in the 70–74 year subgroup in 2005, whereas in 2008, over 90% of women aged 50–74 years had had a mammography in their lifetime. In2008, 66% of women had undergone a mammography as a part of an organized screening programme, versus 45% in 2005. In 2005, 15% of women reported having received no recommendation from their GP, whereas this figure fell to 4% in 2008. In both EDIFICE surveys, two thirds of GPs systematically recommended breast cancer screening to female patients aged 50–74 years; however, female GPs were more likely to systematically recommend this screening. In 2008, 77% of the GPs questioned were aware of the recommended frequency for breast cancer screening, compared with 71% in 2005. Results of studies such as EDIFICE may help increase the proportion of women who undergo breast cancer screening. Successful implementation of organized screening relies heavily on treating physicians. The impact of mammography in breast cancer screening may be further improved by systematic organized screening, by encouraging regular examination and by targeting women who give up screening.

aAvicenne University Hospital, Bobigny

bUniversity Paris XIII, Paris

cUniversity Hospital of Besançon

dINSERM U645, Besançon

eCancer Screening Department, University Hospital Centre of Tours

fLéon Bérard Cancer Center

gINSERM U590, Centre L. Bérard and Conticanet, Lyon

hCapio Clinique du Parc, Toulouse

iPorte de St Cloud Clinic, Boulogne Billancourt

jROCHE S.A., Neuilly-sur-Seine

kPaoli-Calmettes Institute

lINSERM UMR912, Marseille, France

Correspondence to Jean-François Morère, Hôpital Avicenne, Service d'Oncologie Médicale, 125 rue de Stalingrad, 93009 Bobigny Cedex, France Tel: +33 1 48 95 51 32; fax: +33 1 48 95 50 35; e-mail:

© 2011 Lippincott Williams & Wilkins, Inc.